The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells
- PMID: 2168107
- DOI: 10.1007/BF00308567
The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells
Abstract
Sequencing of the VP1 of a large number of subtypes of foot-and-mouth disease virus (FMDV) has revealed the presence of a conserved arginine-glycine-aspartic acid (RGD) sequence located in a highly exposed region. This sequence has been shown to be essential for the interaction of certain extracellular matrix and adhesion proteins with a superfamily of cell-surface receptors called integrins. We have examined the effects of synthetic peptides containing the RGD sequence on the binding of eight different subtypes of FMDV to tissue culture cells. The results showed that such peptides inhibited viral adsorption by 50-80%. The inhibition was dose dependent but not as great as that achieved by using a saturating amount of virus as an inhibitor. Substitution of other amino acids for any of the three main residues lowered the inhibitory properties of the peptides. These results suggest that the RGD sequence in FMDV VP1 appears to be important for the interaction of virus with cellular receptor sites.
Similar articles
-
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).J Gen Virol. 1989 Mar;70 ( Pt 3):625-37. doi: 10.1099/0022-1317-70-3-625. J Gen Virol. 1989. PMID: 2543752
-
[Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?].Bioorg Khim. 1988 Jul;14(7):965-8. Bioorg Khim. 1988. PMID: 2847760 Russian.
-
RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.Acta Virol. 1991 Jan;35(1):90-3. Acta Virol. 1991. PMID: 1683122
-
Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.J Virol. 1997 Nov;71(11):8357-61. doi: 10.1128/JVI.71.11.8357-8361.1997. J Virol. 1997. PMID: 9343190 Free PMC article.
-
Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.J Biotechnol. 1996 Jan 26;44(1-3):83-9. doi: 10.1016/0168-1656(95)00090-9. J Biotechnol. 1996. PMID: 8717390 Review.
Cited by
-
Computer analysis of antigenic domains and RGD-like sequences (RGWG) in the E glycoprotein of flaviviruses: an approach to vaccine development.Virus Genes. 1990 Sep;4(3):267-82. doi: 10.1007/BF00265636. Virus Genes. 1990. PMID: 1702915
-
RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.J Virol. 2004 Jul;78(13):6900-7. doi: 10.1128/JVI.78.13.6900-6907.2004. J Virol. 2004. PMID: 15194766 Free PMC article.
-
Foot and mouth disease virus replication in bovine skin Langerhans cells under in vitro conditions detected by RT-PCR.Virus Genes. 1995;10(1):5-13. doi: 10.1007/BF01724292. Virus Genes. 1995. PMID: 7483289
-
Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor.Virol J. 2014 Jul 24;11:132. doi: 10.1186/1743-422X-11-132. Virol J. 2014. PMID: 25056022 Free PMC article.
-
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1932-6. doi: 10.1073/pnas.91.5.1932. Proc Natl Acad Sci U S A. 1994. PMID: 8127909 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources